Document Detail

Effect of nitrate tolerance and dipyridamole on the response to SIN1 in the human isolated saphenous vein.
MedLine Citation:
PMID:  1906734     Owner:  NLM     Status:  MEDLINE    
The relaxant effects of nitroglycerin (NTG) and SIN1 on human vena saphena magna were studied in vitro. Nitrate tolerance was produced after incubation of the preparation with nitroglycerin (NTG 10 microM for 10 minutes). Vessels precontracted by serotonin (0.25 microM) and made tolerant to NTG exhibited a slight but significant shift (p less than 0.01) to the right of the dose-response curve to SIN1 (EC50 increased from 1.12 +/- 0.21 microM to 2.74 +/- 0.32 microM). The maximal relaxation was unaltered. On the contrary, there was a marked attenuation of the maximal relaxation to NTG in the nitrate-tolerant preparation (maximal relaxation decreased from 73 +/- 2% to 35 +/- 1%). Dipyridamole, a phosphodiesterase (PDe) inhibitor, significantly potentiated the responses to SIN1 on control rings (EC50 = 57.1 +/- 1.8 nM), and on NTG-tolerant rings it reversed the responsiveness to SIN1 (EC50 = 88.9 +/- 9.2 nM), which suggests that nitrate tolerance may be partially due to an increase in PDe activity. In conclusion we have demonstrated a slight cross-tolerance between SIN1 and NTG on human vena saphena magna. Nevertheless, after induction of in vitro NTG tolerance, the attenuation of responses to SIN1 is much less pronounced that the alteration of NTG relaxations.
M Bohyn; G Berkenboom; J Fontaine
Related Documents :
8378744 - The relationship between early insulin release and glucose tolerance in healthy subjects.
6239714 - The effects of cyproterone acetate and ethinyl oestradiol on carbohydrate metabolism.
761734 - Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes").
20153004 - Glycosylphosphatidylinositol-specific phospholipase d improves glucose tolerance.
24069124 - Correction: the value of genetic information for diabetes risk prediction - differences...
20622454 - Cilostazol ameliorates nephropathy in type 1 diabetic rats involving improvement in oxi...
Publication Detail:
Type:  In Vitro; Journal Article    
Journal Detail:
Title:  Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy     Volume:  5     ISSN:  0920-3206     ISO Abbreviation:  Cardiovasc Drugs Ther     Publication Date:  1991 Apr 
Date Detail:
Created Date:  1991-08-29     Completed Date:  1991-08-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8712220     Medline TA:  Cardiovasc Drugs Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  457-61     Citation Subset:  IM    
Anesthesiology Department, Erasmus Hospital, Brussels, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Dipyridamole / pharmacology*
Drug Tolerance
Molsidomine / analogs & derivatives*,  antagonists & inhibitors
Nitroglycerin / pharmacology*
Saphenous Vein / drug effects*
Serotonin / pharmacology
Vasodilator Agents / antagonists & inhibitors*
Reg. No./Substance:
0/Vasodilator Agents; 25717-80-0/Molsidomine; 33876-97-0/3-morpholino-sydnonimine; 50-67-9/Serotonin; 55-63-0/Nitroglycerin; 58-32-2/Dipyridamole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Male endocrine functions in workers with moderate exposure to lead.
Next Document:  The effects of pretreatment with nitroglycerin on ischemic left ventricular dysfunction during coron...